Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background. Compulsive overeating (bulimia nervosa, binge eating disorder) is the basis of eating disorders and is included in ICD-11 and DSM-5 as a manifestation of a non-chemical form of addiction. It is a behavioral disorder of impulsivity and compulsivity. Obesity and eating disorders are characterized by compulsive food consumption, similar to the compulsive drug use of substance use disorders. Aim. Study of the effect of the OX1 receptor antagonist anthorex on compulsive overeating in animals in a model of maternal deprivation. Materials and methods. Sexually mature male rats, which were separated from their mother for 3 hours after birth from days 2 to 12, were fed a high-carbohydrate diet every third day for 1 hour for 45 days. In this case, high-calorie food was placed within 5 cm of reach with visual contact 15 minutes before feeding. Orexin receptor antagonist Anthorex was administered intranasally for 7 days at a dose of 1 µg/1 µl, 20 µl. Results. Intermittent consumption of high-calorie foods caused compulsive overeating in rats. Sexually mature animals that experienced deprivation from their mother in early ontogenesis showed increased signs of compulsive overeating of high-carbohydrate foods in our model relative to the control (p 0.001). At the same time, the consumption of standard briquetted feed did not change. Intranasal administration of the OX1 receptor antagonist anthorex reduced the manifestations of compulsive overeating in rats after weaning under conditions of intermittent consumption of high-calorie food compared to the control group (p 0.05). Consumption of standard food did not differ relative to the control group, both before and after the course of administration of the orexin antagonist. Conclusion. The work suggest new ways of studying and synthesizing peptide drugs based on orexin and its antagonists for the correction of compulsive overeating caused by chronic stress in ontogenesis.
Background. Compulsive overeating (bulimia nervosa, binge eating disorder) is the basis of eating disorders and is included in ICD-11 and DSM-5 as a manifestation of a non-chemical form of addiction. It is a behavioral disorder of impulsivity and compulsivity. Obesity and eating disorders are characterized by compulsive food consumption, similar to the compulsive drug use of substance use disorders. Aim. Study of the effect of the OX1 receptor antagonist anthorex on compulsive overeating in animals in a model of maternal deprivation. Materials and methods. Sexually mature male rats, which were separated from their mother for 3 hours after birth from days 2 to 12, were fed a high-carbohydrate diet every third day for 1 hour for 45 days. In this case, high-calorie food was placed within 5 cm of reach with visual contact 15 minutes before feeding. Orexin receptor antagonist Anthorex was administered intranasally for 7 days at a dose of 1 µg/1 µl, 20 µl. Results. Intermittent consumption of high-calorie foods caused compulsive overeating in rats. Sexually mature animals that experienced deprivation from their mother in early ontogenesis showed increased signs of compulsive overeating of high-carbohydrate foods in our model relative to the control (p 0.001). At the same time, the consumption of standard briquetted feed did not change. Intranasal administration of the OX1 receptor antagonist anthorex reduced the manifestations of compulsive overeating in rats after weaning under conditions of intermittent consumption of high-calorie food compared to the control group (p 0.05). Consumption of standard food did not differ relative to the control group, both before and after the course of administration of the orexin antagonist. Conclusion. The work suggest new ways of studying and synthesizing peptide drugs based on orexin and its antagonists for the correction of compulsive overeating caused by chronic stress in ontogenesis.
BACKGROUND. Depressive states are becoming an increasingly common mental disorder, as well as a serious social problem that places a heavy economic burden on society. More and more data from preclinical and clinical studies indicate that orexins (neuropeptides, also known as hypocretins) and their receptors are involved in the pathogenesis of depression. The orexinergic system regulates functions that are disrupted in depressive states, such as sleep, reward system, eating behavior, stress response and monoaminergic regulation. However, the exact role of orexins in behavioral and neurophysiological disorders observed in depression is still unclear. AIM. To study the effect of early postnatal stress on the expression of OX1R orexin in the limbic system of the brain and the development of anxiety-depressive symptoms in rats. MATERIALS AND METHODS. In the work, maternal deprivation was used as a model of early postnatal stress (from the 2nd to the 12th postpartum day). Two experimental groups were formed: control (n = 20); "maternal deprivation" (n = 20). On the 90th day of life, the influence of early postnatal stress on the development of anxiety-depressive symptoms in rats in adulthood was analyzed using a package of behavioral tests. Behavior analysis was performed using the following tests: raised cruciform maze, forced swimming Porsolt test, two-bottle test. After the experiments, the animals were killed by decapitation, the brain was extracted, placed in the cold and brain structures (hypothalamus, amygdala) were isolated, immediately frozen in liquid nitrogen and stored at a temperature of -80 C until PCR analysis was performed. RESULTS. Testing of experimental animals in the "Raised cruciform maze" showed that in a group of animals subjected to deprivation from the mother, there was a decrease in the time spent in the open arms of the maze, and the time spent in the closed sleeves increased relative to the control, which can be assessed as an increase in the level of anxiety of animals. In the Porsolt test, the maternal deprivation group had an increased immobilization time relative to the control group of animals. In the maternal deprivation group, under the conditions of a two-bottle sucrose preference test, there was a decrease in sucrose solution preference, which indicates the development of anhedonia. In the hypothalamus, there was a statistically significant decrease in the expression of OX1R mRNA in the experimental group of animals, in contrast to the intact control group. A two-fold decrease in the level of OX1R mRNA expression in the experimental group relative to the control animals was also observed in the amygdala. CONCLUSION. Early stress of maternal deprivation causes a decrease in the expression of OX1R orexin in the hypothalamus and amygdala of the brain and contributes to the development of anxiety-depressive symptoms in rats.
The study of the role of social isolation in the pathogenesis of addictive behavior disorders is an important medical and biological problem. Of particular importance are the limitations of social experience in ontogenesis. This work makes an attempt to find a connection between social isolation in ontogenesis and impulsive-compulsive behavior, as an indicator of the premorbid background for gaming and other forms of behavioral addictions. The mechanisms of addictive behavior in rats reared in isolation (IS) were investigated by analyzing the extracellular release of dopamine in response to stimulation of the positive reinforcing zone. Before the experiments, male rats were kept in individual cages from the 21st day of birth to the 90th day. To study elements of addictive behavior, a variant of the Iowa Gambling Task in a 3-arm maze and a method of developing compulsive overeating using intermittent consumption of high-calorie foods were used. To study compulsive behavior, a marble test was used against the background of withdrawal from a high-calorie diet. Surgeries were performed to implant electrodes into the ventral tegmental area (VTA) and the nucleus accumbens in rats exhibiting elements of addictive behavior in the 3-arm maze. These animals were then trained to respond to VTA self-stimulation. Dopamine release was recorded telemetrically in freely moving rats in response to electrical stimulation of the VTA self-stimulation zone. Fast scan cyclic voltammetry was used to determine changes in dopamine levels in the extracellular environment of the nucleus accumbens. IS entered less into the arm with a high degree of probability but with a low reward, and entered more in the arm with a low degree of probability, but with a high reward, which is associated with the appearance of impulsivity in behavior. In the model of compulsive overeating, the number of approaches to the feeder in IS increased, and against the background of withdrawal of high-calorie food, IS were more active in the marble test. In IS exhibiting elements of addictive behavior in the 3-arm maze, the content of extracellular dopamine in response to electrical stimulation of the VTA self-stimulation zones did not reveal any differences compared to the control group of rats with addictive behavior in the maze. At the same time, IS exhibiting elements of addictive behavior in the maze showed a more pronounced dopamine response to a complex stimulus: a conditioned signal used during maze learning light + VTA stimulation. Thus, rearing in the IS causes an increase in dopamine release in the nucleus accumbens in response to stimulation of the positive reinforcement area associated with addictive behaviors: impulsivity and compulsivity. A conclusion is drawn about the prospects of studying the extracellular release of dopamine and assesses addictive behavior disorders caused by limited social contacts in ontogenesis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.